If you work with women of child-bearing age you’ve probably heard of Polycystic Ovarian Syndrome (PCOS). Increasingly common amongst this population, it’s thought that around 1 in 10 Australian women are affected.
With insulin resistance a key hallmark, it’s unsurprising that women with PCOS are 4 times as likely to develop type 2 diabetes (T2D), making glycaemic assessment imperative.
Amongst those at higher risk include Aboriginal and Torres Strait Islander women and those with a family history of PCOS or T2D. Also interesting is the increased prevalence amongst women with type 1 diabetes, with almost twice as many thought to be affected as the general population.
A recent article in the Diabetes Management Journal summarised some of the key points of the new clinical guidelines for complex endocrine condition, outlining some of its key features and the unique considerations when managing both PCOS and diabetes. Click here to read the full article published in the November 2018 issue PCOS article